טוען...
Regulation of VEGF by mevalonate pathway inhibition in breast cancer
Aminobisphosphonates are used for the treatment of benign and malignant bone disorders. As inhibitors of the mevalonate pathway they exert direct anti-tumor effects in vitro and in preclinical models of bone metastases. Bisphosphonates are thought to have an anti-angiogenic activity as decreased lev...
שמור ב:
| הוצא לאור ב: | J Bone Oncol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4723384/ https://ncbi.nlm.nih.gov/pubmed/26909280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2013.05.003 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|